cagrisema vs semaglutide Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study Novo Nordisk's CagriSema outperforms Ozempic

It is important to be honest about what to expect, and we always are

This can lead to: Increased calorie burning Enhanced fat metabolism Reduced metabolic slowdown during weight loss This metabolic activity helps support continued progress rather than early plateaus

doi:10.1016/j.cell.2005.08.029

These medications mimic the action of the hormone GLP-1 (glucagon-like peptide-1), which helps manage blood sugar levels by stimulating insulin release, reducing glucagon secretion, and slowing gastric emptying

In individuals with diabetes who are diagnosed with heart or blood vessel problems, this medication is also used to reduce the risk of a heart attack, stroke, or death